Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

28.53

+0.65 (2.33%)

Nov 6, 2026, 4:00 PM EST - Market closed

Parabilis Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	3,524	-	-
Market Cap Growth	-	-	-
Enterprise Value	2,451	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.05	-3.55	1.17
Net Debt / Equity Ratio	-1.02	-1.87	-0.39
Net Debt / EBITDA Ratio	6.35	-0.21	0.18
Net Debt / FCF Ratio	9.54	-0.25	0.21
Quick Ratio	17.83	0.49	2.77
Current Ratio	17.91	0.52	2.85
Return on Equity (ROE)	-	-731.00%	-
Return on Assets (ROA)	-	-80.33%	-
Return on Capital Employed (ROCE)	-15.40%	-615.30%	-104.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-4.59%	-

SEC Filings: 10-K · 10-Q